The earlier that cancer is found, the higher the chance of successful treatment and survival. Yet,
for many people, the detection of cancer often happens after a tumor has already progressed to mid
to late stages.
Genetron operates a digital tumor resource library for genomics, epiomics, and expression profiling. This big
data center enables our team to develop artificial intelligence recognition and learning, upkeep pathology and
imaging data, as well as store a complete precision medical records database to provide integrated clinical
and scientific research services.
Genetron Health has R&D centers in China and the United States, 2 medical device production bases that have passed ISO13485:2016 and ISO9001:2015 system certifications, and 5 clinical laboratories bases located in Shanghai, Hangzhou, Chongqing, Guangzhou, and Beijing (CAP accreditation, CLIA certification).